WallStreetZenWallStreetZen

NYSEMKT: PHGE
Biomx Inc Stock

$0.34+0.00 (+0%)
Updated May 20, 2024
PHGE Price
$0.34
Fair Value Price
N/A
Market Cap
$18.89M
52 Week Low
$0.19
52 Week High
$0.86
P/E
-0.67x
P/B
6.13x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$26.17M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
7.12
Operating Cash Flow
-$21M
Beta
0.4
Next Earnings
Jun 19, 2024
Ex-Dividend
N/A
Next Dividend
N/A

PHGE Overview

BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PHGE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PHGE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PHGE is poor value based on its book value relative to its share price (6.13x), compared to the US Biotechnology industry average (6.06x)
P/B vs Industry Valuation
PHGE is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PHGE due diligence checks available for Premium users.

Be the first to know about important PHGE news, forecast changes, insider trades & much more!

Valuation

PHGE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.67x
Industry
8.16x
Market
31.12x

PHGE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.13x
Industry
6.06x
PHGE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PHGE's financial health

Profit margin

Revenue
$0.0
Net Income
-$5.5M
Profit Margin
0%
PHGE's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$25.0M
Liabilities
$21.9M
Debt to equity
7.12
PHGE's short-term assets ($17.63M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PHGE's short-term assets ($17.63M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PHGE's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
PHGE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.2M
Investing
-$6.0k
Financing
-$1.3M
PHGE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PHGE vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
PHGE$18.89M+0.88%-0.67x6.13x
ORGS$18.94M-0.36%0.40x-0.68x
SYBX$18.97M-1.82%-0.20x1.42x
APTO$18.76M-2.54%-0.19x136.90x
GLYC$18.63M-3.34%-0.50x0.64x

Biomx Stock FAQ

What is Biomx's quote symbol?

(NYSEMKT: PHGE) Biomx trades on the NYSEMKT under the ticker symbol PHGE. Biomx stock quotes can also be displayed as NYSEMKT: PHGE.

If you're new to stock investing, here's how to buy Biomx stock.

What is the 52 week high and low for Biomx (NYSEMKT: PHGE)?

(NYSEMKT: PHGE) Biomx's 52-week high was $0.86, and its 52-week low was $0.19. It is currently -60% from its 52-week high and 82.89% from its 52-week low.

How much is Biomx stock worth today?

(NYSEMKT: PHGE) Biomx currently has 55,220,077 outstanding shares. With Biomx stock trading at $0.34 per share, the total value of Biomx stock (market capitalization) is $18.89M.

Biomx stock was originally listed at a price of $10.00 in Dec 14, 2018. If you had invested in Biomx stock at $10.00, your return over the last 5 years would have been -96.58%, for an annualized return of -49.09% (not including any dividends or dividend reinvestments).

How much is Biomx's stock price per share?

(NYSEMKT: PHGE) Biomx stock price per share is $0.34 today (as of May 20, 2024).

What is Biomx's Market Cap?

(NYSEMKT: PHGE) Biomx's market cap is $18.89M, as of May 21, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Biomx's market cap is calculated by multiplying PHGE's current stock price of $0.34 by PHGE's total outstanding shares of 55,220,077.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.